Advertisement
Screener

MeiraGTx Holdings plc (MGTX) EBITDA

MeiraGTx Holdings plc (MGTX) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $247.25M*; Operating income $244.43M; Depreciation and amortization $2.82M*.
  • 2026-03-31: Basis Reported; EBITDA -$37.81M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $29.59M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$42.9M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$247.25M*$244.43M$2.82M*(m)(m)$332.00K*-$38.54M*(m)$57.83M(m)$2.36M
2026-03-31Reported-$37.81M(m)(m)(m)-12904.10%$2.01M$17.81M(m)$31.98M(m)$0.00
2025-12-31Reported$29.59M(m)(m)(m)39.26%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$42.9M(m)(m)(m)-10462.44%$610.00K*-$12.21M*(m)$32.53M(m)$0.00*
2025-06-30Reported-$41.6M(m)(m)(m)-1127.15%$1.23M*-$43.95M*(m)$33.49M(m)$0.00*
2025-03-31Reported-$38.52M(m)(m)(m)-1999.74%$1.71M-$36.83M(m)$32.78M(m)$0.00
2024-12-31Reported-$28.42M(m)(m)(m)-132.86%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$36.78M(m)(m)(m)-337.14%$730.00K*-$25.02M*(m)$26.24M(m)$0.00
2024-06-30Reported-$42.69M(m)(m)(m)-15137.94%$1.33M*-$19.46M*(m)$34.93M(m)$0.00
2024-03-31Reported-$43.5M(m)(m)(m)-6240.60%$1.68M-$36.74M(m)$34.32M(m)$0.00
2023-12-31Reported-$39.84M(m)(m)(m)-1953.04%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$29.28M*-$32.76M$3.48M*$5.10M-573.84%*$3.56M*-$24.41M*(m)$27.86M(m)$0.00
2023-06-30Reported-$25.54M*-$28.79M$3.25M*$3.54M-721.41%*$4.97M*-$29.01M*(m)$19.94M(m)$0.00
2023-03-31Reported-$28.67M(m)(m)(m)-859.87%$8.61M-$37.39M(m)$22.32M(m)$0.00
2022-12-31Reported-$38.56M(m)(m)(m)729.25%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$20.78M*-$22.81M$2.03M*$4.82M-431.48%*$10.01M*-$20.73M*(m)$16.86M(m)$0.00
2022-06-30Reported-$21.67M*-$23.76M$2.08M*$10.76M-201.44%*$14.00M*-$27.81M*(m)$24.00M(m)$0.00
2022-03-31Reported-$26.62M(m)(m)(m)-472.50%$12.46M-$8.30M(m)$23.10M(m)$0.00
2021-12-31Reported-$5.63M(m)(m)(m)-26.75%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$20.52M*-$22.55M$2.04M*$6.95M-295.26%*$11.90M*-$17.18M*(m)$21.61M(m)$0.00
2021-06-30Reported-$18.47M*-$20.48M$2.02M*$5.12M-360.97%*$5.58M*-$21.26M*(m)$15.19M(m)$0.00
2021-03-31Reported-$20.27M(m)(m)(m)-441.22%$4.50M$9.09M(m)$16.71M(m)$0.00
2020-12-31Reported-$11.87M(m)(m)(m)-313.28%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$7.37M*-$8.43M$1.06M*$5.09M-144.64%*$5.96M*-$9.14M*(m)$4.63M(m)$0.00
2020-06-30Reported-$24.28M*-$25.23M$941.00K*$2.47M-981.57%*$2.92M*-$12.88M*(m)$16.20M(m)$0.00
2020-03-31Reported-$14.86M(m)(m)(m)-353.06%$4.04M-$12.38M(m)$8.08M(m)$0.00
2019-09-30Reported(m)-$10.91M(m)$3.58M(m)$2.02M*-$18.41M*(m)$4.61M(m)-$338.67K
2019-06-30Reported(m)-$21.23M(m)$1.98M(m)$1.09M*-$21.74M*(m)$9.77M(m)-$91.39K
2019-03-31Reported(m)-$20.69M(m)$784.96K(m)$1.12M$82.17M(m)$12.98M(m)$0.00
2018-09-30Reported(m)-$14.74M(m)(m)(m)$1.05M*-$10.99M*(m)$8.11M(m)$0.00
2018-06-30Reported(m)-$25.17M(m)(m)(m)$107.56K*-$19.03M*(m)$7.79M(m)$0.00
2018-03-31Reported(m)-$18.05M(m)(m)(m)$1.21M-$17.40M(m)$6.93M(m)$0.00
2017-09-30Reported(m)-$8.76M(m)(m)(m)$3.56M*-$3.82M*(m)$6.39M(m)$0.00
2017-06-30Reported(m)-$7.59M(m)(m)(m)(m)(m)(m)$5.36M(m)$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$93.43M(m)(m)(m)-114.79%$3.83M-$46.36M(m)$129.62M(m)$0.00
2024-12-31Reported-$151.38M(m)(m)(m)-454.89%$4.96M-$104.50M(m)$119.48M(m)$0.00
2023-12-31Reported-$123.33M(m)(m)(m)-879.87%$20.17M-$105.36M(m)$103.78M(m)$0.00
2022-12-31Reported-$107.63M(m)(m)(m)-676.08%$44.96M-$73.10M(m)$85.72M(m)(m)
2021-12-31Reported-$64.89M(m)(m)(m)-172.10%$46.35M-$10.53M(m)$66.69M(m)$0.00
2020-12-31Reported-$58.38M(m)(m)(m)-375.13%$20.92M-$63.97M(m)$33.91M(m)$0.00
2019-12-31Reported-$56.03M(m)(m)(m)-421.53%$8.98M$20.04M(m)$24.88M(m)$0.00
2018-12-31Reported(m)-$78.10M(m)(m)(m)$11.26M-$58.89M(m)$33.62M(m)-$474.39K
2017-12-31Reported(m)-$31.68M(m)(m)(m)$10.54M-$18.06M(m)$22.36M(m)$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10